| scholarly article | Q13442814 |
| P2093 | author name string | Xin Wang | |
| Xue Li | |||
| Zhong Chao Han | |||
| Zhibo Han | |||
| Shimin Yang | |||
| Xiaodan Qu | |||
| Ranhua Jiang | |||
| Guangsheng Zhuo | |||
| Yuankang Shao | |||
| P2860 | cites work | Identification of human placenta-derived mesenchymal stem cells involved in re-endothelialization | Q84593477 |
| Transplantation of insulin-producing cells derived from umbilical cord stromal mesenchymal stem cells to treat NOD mice | Q84760589 | ||
| Multilineage potential of adult human mesenchymal stem cells | Q27860737 | ||
| Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views | Q28251015 | ||
| Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study | Q29617267 | ||
| Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells | Q29618766 | ||
| Mesenchymal progenitor cells in human umbilical cord blood | Q30168979 | ||
| Treatment of type 1 diabetes with adipose tissue-derived stem cells expressing pancreatic duodenal homeobox 1. | Q33820318 | ||
| Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta | Q33855709 | ||
| Mesenchymal stem cells: biology and potential clinical uses | Q34034011 | ||
| Placenta as a newly identified source of hematopoietic stem cells | Q34089486 | ||
| Mesenchymal stromal cells: current understanding and clinical status | Q34234464 | ||
| Islet Regeneration During the Reversal of Autoimmune Diabetes in NOD Mice | Q34276533 | ||
| A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction | Q36634299 | ||
| Placenta as a source of hematopoietic stem cells | Q36650764 | ||
| Insulin-producing cells derived from stem cells: recent progress and future directions | Q36663038 | ||
| Concise review: isolation and characterization of cells from human term placenta: outcome of the first international Workshop on Placenta Derived Stem Cells | Q36987698 | ||
| Mesenchymal stem cells: biology and clinical potential in type 1 diabetes therapy | Q37094023 | ||
| Comparison of cytokine expression in mesenchymal stem cells from human placenta, cord blood, and bone marrow | Q37284748 | ||
| Regenerative medicine for diabetes mellitus | Q37602279 | ||
| Bone marrow and pancreatic islets: an old story with new perspectives | Q37780807 | ||
| Prevalence of diabetes among men and women in China | Q39605920 | ||
| CD14+ monocytes promote the immunosuppressive effect of human umbilical cord matrix stem cells | Q39879492 | ||
| Cytokines as the major mechanism of mesenchymal stem cell clinical activity: expanding the spectrum of cell therapy | Q39963052 | ||
| Cardiac potential of stem cells from whole human umbilical cord tissue. | Q39977861 | ||
| Placenta-derived stem cells: new hope for cell therapy? | Q41335642 | ||
| Human umbilical cord mesenchymal stem cells hUC-MSCs exert immunosuppressive activities through a PGE2-dependent mechanism | Q43140862 | ||
| Efficacy of autologous bone marrow-derived stem cell transplantation in patients with type 2 diabetes mellitus | Q43290819 | ||
| Therapeutic effect of human umbilical cord multipotent mesenchymal stromal cells in a rat model of stroke. | Q43765540 | ||
| Prevalence and risk factors for type 2 diabetes mellitus in the Chinese adult population: the InterASIA Study | Q45038988 | ||
| [Study on prevalence of latent autoimmune diabetes in adults and its relationship with metabolic syndrome]. | Q45931056 | ||
| Adult human mesenchymal stem cells added to corticosteroid therapy for the treatment of acute graft-versus-host disease. | Q45962719 | ||
| Differentiation of human umbilical cord mesenchymal stromal cells into low immunogenic hepatocyte-like cells. | Q45975180 | ||
| The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study | Q46576373 | ||
| Autologous mesenchymal stem cell therapy delays the progression of neurological deficits in patients with multiple system atrophy. | Q46979432 | ||
| Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. | Q51155330 | ||
| Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial. | Q51775892 | ||
| Human placenta-derived cells have mesenchymal stem/progenitor cell potential. | Q52087798 | ||
| Surface protein characterization of human adipose tissue-derived stromal cells | Q74559072 | ||
| Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta | Q81096492 | ||
| Manufacturing of human placenta-derived mesenchymal stem cells for clinical trials | Q82938423 | ||
| Human multipotent mesenchymal stromal cells from fetal lung expressing pluripotent markers and differentiating into cell types of three germ layers | Q84340264 | ||
| P433 | issue | 1 | |
| P921 | main subject | mesenchymal stem cell | Q1922379 |
| type 2 diabetes | Q3025883 | ||
| P304 | page(s) | 94-100 | |
| P577 | publication date | 2011-03-17 | |
| P1433 | published in | Frontiers of medicine | Q26867043 |
| P1476 | title | Transplantation of placenta-derived mesenchymal stem cells in type 2 diabetes: a pilot study | |
| P478 | volume | 5 |
| Q33746422 | A preliminary evaluation of efficacy and safety of Wharton's jelly mesenchymal stem cell transplantation in patients with type 2 diabetes mellitus. |
| Q95360893 | A review of clinical trials: mesenchymal stem cell transplant therapy in type 1 and type 2 diabetes mellitus |
| Q36382445 | Activation of Toll-like receptor 3 amplifies mesenchymal stem cell trophic factors and enhances therapeutic potency |
| Q33759539 | Adipose stem cell-based regenerative medicine for reversal of diabetic hyperglycemia |
| Q24609292 | Adverse effect of high glucose concentration on stem cell therapy |
| Q39180886 | Allogeneic bone marrow-derived mesenchymal stromal cells for hepatitis B virus-related acute-on-chronic liver failure: A randomized controlled trial |
| Q39370965 | Alternatives to islet transplantation: future cell sources of beta-like cells |
| Q92910500 | Applicability of adipose-derived mesenchymal stem cells in treatment of patients with type 2 diabetes |
| Q37987428 | Application of autologous stem cell transplantation in various adult and pediatric rheumatic diseases |
| Q42593149 | Autologous stromal vascular fraction therapy for rheumatoid arthritis: rationale and clinical safety |
| Q36272379 | Basic Fibroblast Growth Factor Inhibits Apoptosis and Promotes Proliferation of Adipose-Derived Mesenchymal Stromal Cells Isolated from Patients with Type 2 Diabetes by Reducing Cellular Oxidative Stress |
| Q91891770 | Cell-based interferon gene therapy using proliferation-controllable, interferon-releasing mesenchymal stem cells |
| Q26748676 | Clinical Efficacy of Stem Cell Therapy for Diabetes Mellitus: A Meta-Analysis |
| Q55014920 | Clinical performance of stem cell therapy in patients with acute-on-chronic liver failure: a systematic review and meta-analysis. |
| Q37056276 | Concise review: mesenchymal stem cells and translational medicine: emerging issues. |
| Q90049975 | Considerations on the harvesting site and donor derivation for mesenchymal stem cells-based strategies for diabetes |
| Q92970977 | Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus |
| Q38257522 | Design strategies of biodegradable scaffolds for tissue regeneration |
| Q36931550 | Developing a New Two-Step Protocol to Generate Functional Hepatocytes from Wharton's Jelly-Derived Mesenchymal Stem Cells under Hypoxic Condition |
| Q43648419 | Effect of combined therapy of human Wharton's jelly-derived mesenchymal stem cells from umbilical cord with sitagliptin in type 2 diabetic rats |
| Q43046013 | Effect of mesenchymal stem cells transplantation on glycaemic profile & their localization in streptozotocin induced diabetic Wistar rats |
| Q58634190 | Efficacy and Safety of Autologous Bone Marrow-Derived Stem Cell Transplantation in Patients with Type 2 Diabetes Mellitus: A Randomized Placebo-Controlled Study |
| Q41955327 | Emerging stem cell therapies: treatment, safety, and biology |
| Q37723500 | Enhancing the efficacy of mesenchymal stem cell therapy |
| Q37253767 | Fibrin glue improves the therapeutic effect of MSCs by sustaining survival and paracrine function. |
| Q38710399 | Focal adhesion kinase signaling regulates anti-inflammatory function of bone marrow mesenchymal stromal cells induced by biomechanical force |
| Q37989191 | From tendon to nerve: an MSC for all seasons |
| Q34337632 | Functional melanocytes are readily reprogrammable from multilineage-differentiating stress-enduring (muse) cells, distinct stem cells in human fibroblasts. |
| Q38032498 | Harnessing the immunomodulatory and tissue repair properties of mesenchymal stem cells to restore β cell function |
| Q40920077 | Human mesenchymal stem cells alter the gene profile of monocytes from patients with Type 2 diabetes and end-stage renal disease. |
| Q38189400 | Human term placental cells: phenotype, properties and new avenues in regenerative medicine |
| Q61815267 | IL-27 Promotes Human Placenta-Derived Mesenchymal Stromal Cell Ability To Induce the Generation of CD4IL-10IFN-γ T Cells via the JAK/STAT Pathway in the Treatment of Experimental Graft-versus-Host Disease |
| Q89833740 | Immunomodulation by Mesenchymal Stromal Cells and Their Clinical Applications |
| Q37988754 | Immunomodulatory properties of mesenchymal stem cells and their therapeutic applications |
| Q50510612 | In vitro differentiation of osteocytes and adipocytes from human placenta-derived cells. |
| Q35976735 | Infusion of mesenchymal stem cells ameliorates hyperglycemia in type 2 diabetic rats: identification of a novel role in improving insulin sensitivity |
| Q38099034 | Large-scale production of human mesenchymal stem cells for clinical applications. |
| Q92612721 | Liraglutide combined with human umbilical cord mesenchymal stem cell transplantation inhibits beta-cell apoptosis via mediating the ASK1/JNK/BAX pathway in rats with type 2 diabetes |
| Q37204124 | Long term effect and safety of Wharton's jelly-derived mesenchymal stem cells on type 2 diabetes |
| Q37424076 | Long-term cultured mesenchymal stem cells frequently develop genomic mutations but do not undergo malignant transformation |
| Q50238199 | Long-term safety of umbilical cord mesenchymal stem cells transplantation for systemic lupus erythematosus: a 6-year follow-up study. |
| Q33691629 | Mesenchymal stem cell therapy in type 2 diabetes mellitus |
| Q37357426 | Mesenchymal stem cell transplantation for the infarcted heart: therapeutic potential for insulin resistance beyond the heart |
| Q58799669 | Mesenchymal stem cells ameliorate hyperglycemia-induced endothelial injury through modulation of mitophagy |
| Q57174143 | Mesenchymal stem cells and immune disorders: from basic science to clinical transition |
| Q26770191 | Mesenchymal stem cells and immunomodulation: current status and future prospects |
| Q26853374 | Mesenchymal stem cells as a vector for the inflammatory prostate microenvironment |
| Q42636758 | Mesenchymal stem cells from umbilical cord matrix, adipose tissue and bone marrow exhibit different capability to suppress peripheral blood B, natural killer and T cells. |
| Q35552255 | Metabolic and pancreatic effects of bone marrow mesenchymal stem cells transplantation in mice fed high-fat diet. |
| Q35301752 | Multi-lineage differentiation of human umbilical cord Wharton's Jelly Mesenchymal Stromal Cells mediates changes in the expression profile of stemness markers |
| Q55070738 | Oscillatory shear stress mediates directional reorganization of actin cytoskeleton and alters differentiation propensity of mesenchymal stem cells. |
| Q64983057 | Placenta-Derived Adherent Stromal Cell Therapy for Hematopoietic Disorders: A Case Study of PLX-R18. |
| Q38574530 | Pulp-dentin Regeneration: Current State and Future Prospects. |
| Q92247218 | Regenerative Capacity of Adipose Derived Stem Cells (ADSCs), Comparison with Mesenchymal Stem Cells (MSCs) |
| Q64058465 | Shaping the Future of Perinatal Cells: Lessons From the Past and Interpretations of the Present |
| Q26795447 | Stem Cells and Regenerative Medicine: Myth or Reality of the 21th Century |
| Q38178875 | Stem cell therapies and regenerative medicine in China |
| Q33768112 | Stem cell therapies for the treatment of radiation-induced normal tissue side effects |
| Q64948643 | Stem cell therapy for patients with diabetes: a systematic review and meta-analysis of metabolomics-based risks and benefits. |
| Q51335986 | Stirred tank bioreactor culture combined with serum-/xenogeneic-free culture medium enables an efficient expansion of umbilical cord-derived mesenchymal stem/stromal cells. |
| Q89496687 | The Clinical Efficacy and Safety of Stem Cell Therapy for Diabetes Mellitus: A Systematic Review and Meta-Analysis |
| Q26779265 | The Long Path of Human Placenta, and Its Derivatives, in Regenerative Medicine |
| Q54185892 | The immunologic and hematopoietic profiles of mesenchymal stem cells derived from different sections of human umbilical cord. |
| Q38181982 | The potential of cell-based therapy for diabetes and diabetes-related vascular complications |
| Q97525008 | Therapeutic effect of integrin-linked kinase gene-modified bone marrow-derived mesenchymal stem cells for streptozotocin-induced diabetic cystopathy in a rat model |
| Q87412482 | Therapeutic effects of stem cell on hyperglycemia, hyperlipidemia, and oxidative stress in alloxan-treated rats |
| Q39455373 | Therapeutic potential of mesenchymal stem cells for diabetes |
| Q36737833 | Therapeutic potential of mesenchymal stem cells in regenerative medicine |
| Q47547317 | Three-week topical treatment with placenta-derived mesenchymal stem cells hydrogel in a patient with diabetic foot ulcer: A case report |
| Q36097710 | Transplantation of Human Placenta-Derived Mesenchymal Stem Cells Alleviates Critical Limb Ischemia in Diabetic Nude Rats |
| Q37714129 | Transplantation of betatrophin-expressing adipose-derived mesenchymal stem cells induces β-cell proliferation in diabetic mice |
| Q33767123 | Umbilical cord mesenchymal stem cell transplantation in active and refractory systemic lupus erythematosus: a multicenter clinical study |
| Q37967561 | Unravelling the pluripotency paradox in fetal and placental mesenchymal stem cells: Oct-4 expression and the case of The Emperor's New Clothes |
Search more.